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Signaling pathways are controlled by a vast array of
posttranslational mechanisms. By contrast, little is
known regarding the mechanisms that regulate the
expression of their core components. We conducted
an RNAi screen in Drosophila for factors modulating
RAS/MAPK signaling and identified the Exon Junc-
tion Complex (EJC) as a key element of this pathway.
The EJC binds the exon-exon junctions of mRNAs
and thus far, has been linked exclusively to post-
splicing events. Here, we report that the EJC is
required for proper splicing of mapk transcripts by
a mechanism that apparently controls exon defini-
tion. Moreover, whole transcriptome and RT-PCR
analyses of EJC-depleted cells revealed that the
splicing of long intron-containing genes, which
includes mapk, is sensitive to EJC activity. These
results identify a role for the EJC in the splicing of a
subset of transcripts and suggest that RAS/MAPK
signaling depends on the regulation of MAPK levels
by the EJC.
INTRODUCTION
The RAS/MAPK signaling pathway is linked to a wide range of
cellular processes that include proliferation, differentiation and
survival (Kolch, 2005). Its critical role in oncogenesis and various
developmental disorders has also been recognized early on and
abundantly studied (Schubbert et al., 2007; Zebisch et al., 2007).
The pathway is minimally defined by the small GTPase RAS and
a core of three kinases (RAF, MEK and ERK/MAPK) that transmit
signals incoming mostly from plasma membrane receptors.
Upon its activation by a Guanine nucleotide Exchange Factor
(GEF), GTP-loaded RAS triggers RAF activation, which in turn
phosphorylates MEK. Activated MEK then phosphorylates and
activates MAPK. MAPK then phosphorylates a specific set ofsubstrates that will elicit distinct cell responses (McKay andMor-
rison, 2007; Turjanski et al., 2007).
Within recent years, it has become apparent that the RAS/
MAPK pathway is not merely a linear route involving only four
proteins as commonly referred to, but in fact corresponds to
a larger protein network that comprises multiple regulatory char-
acteristics such as feedback loops (Dougherty et al., 2005),
compartmentalization (Ebisuya et al., 2005; McKay and Morri-
son, 2007) and crosstalk with other pathways (Hurlbut et al.,
2007). However, many of the features inherent to this network
are still poorly understood and its protein composition remains
incompletely defined. Despite their diversity, these regulatory
mechanisms typically affect the enzymatic activity of the core
components or the accessibility to their substrates (Kolch,
2005; McKay and Morrison, 2007). Although much less docu-
mented, mounting evidence suggests that the pathway is also
influenced by other means that affect the steady-state levels of
core components. For example, the expression of LET-60/RAS
in C. elegans or mammalian RAS proteins has been shown to
be modulated by the let-7 family miRNAs (Johnson et al.,
2005). More recently, PumiliomRNAbinding proteins were found
to restrict MAPK activity by attenuating the expression of the
C. elegans MAPK, Mpk-1, as well as ERK2/MAPK1 and p38a/
MAPK14 in human ES cells, which occurred via the binding of
specific sites in the 30UTR of their respective transcripts (Lee
et al., 2007). Moreover, the LARP-1 RNA-binding protein has
also been shown to control the mRNA abundance of RAS/MAPK
pathway components, including those of MAPK in theC. elegans
germ line (Nykamp et al., 2008). Thus, it appears that the expres-
sion of the core components themselves can be the target of
specific mechanisms that in turn impact signaling output.
In order to identify novel factors that modulate RAS/MAPK
signaling, we conducted a genome-wide RNAi screen in
Drosophila S2 cells. Interestingly, the screen led to the identifica-
tion of the Exon Junction Complex (EJC) as a critical factor
that specifically impacts MAPK protein levels in Drosophila.
The EJC has recently emerged as an important determinant in
many aspects of mRNA regulation (Tange et al., 2004). This
protein complex is deposited on mRNAs 20-24 nucleotidesCell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc. 251
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Figure 1. EJC Components Functionally Impact RAS1/MAPK
Signaling Downstream of MEK
(A) Schematic representations of the MAPK and JNK pathways. The stimuli
used in the different cell-based functional assays are positioned within these
pathway models (colored text).
(B) Epistasis analysis of the nuclear EJC components. Quantitative micros-
copy-based measurement of the average pMAPK intensity/cell for quadrupli-
cate pMet-Ras1V12 S2 cell samples and duplicate pMet-rafCT and pMet-mekEE
S2 cell line samples treated with the indicated dsRNAs. dsRNA probes target-
ingmapk/rl and cnkwere added as controls of the epistasis strategy; cnk func-
tions between RAS1 and RAF and MAPK functions downstream of MEK.
(C) Values from RTK-based MAPK activation assays (orange) and RAC1V12-
based activation of JNK (purple) are shown for S2 cells treated with the indi-
cated dsRNAs. The average pMAPK intensity/cell is shown for duplicate
samples of insulin treated S2 cells, pMet-Egfr S2 cells treated with Spitz
(EGFR + SPI) and heat-shock induced pHS-SevS11 cells. The average pJNK
intensity/cell is shown for duplicate samples of pMet-Rac1V12 S2 cells.upstream of exon-exon junctions in a splicing-dependent
manner and serves as a tether for other peripheral factors that
are associated with various activities. Three main functions for
the EJC have been described to date, namely, the nuclear
export/subcellular localization of specific transcripts (Hachet
and Ephrussi, 2004; Le Hir et al., 2001b; Palacios et al., 2004),
translational enhancement (Diem et al., 2007; Nott et al., 2004;
Wiegand et al., 2003) and nonsense mediated mRNA decay
(NMD) (Gatfield et al., 2003; Gehring et al., 2003; Lykke-Ander-
sen et al., 2001; Palacios et al., 2004), which is an mRNA surveil-
lance mechanism that eliminates faulty transcripts harboring
premature stop codons (Chang et al., 2007). A few species-
specific exceptions exist to these roles; for instance, the EJC
does not appear to mediate NMD in Drosophila, C. elegans or
S. pombe (Gatfield et al., 2003; Longman et al., 2007; Wen and
Brogna, 2010). The EJC is comprised of four core components:
EIF4A3, MAGOH, RBM8A/Y14 and MLN51. These are respec-
tively known in flies as EIF4AIII, Mago Nashi (MAGO), Tsunagi
(TSU) and Barentz (BTZ), which wewill refer to herein. In contrast
to the other EJC core factors, BTZ is predominantly cytoplasmic
(Degot, 2004; Macchi et al., 2003; Palacios et al., 2004) and is
thought to be added to the complex upon mRNA export from
the nucleus, thus forming the cytoplasmic EJC. It is this config-
uration of the EJC that is involved in mRNA localization and
NMD (Palacios et al., 2004). The nuclear EJC (EIF4AIII/MAGO/
TSU) can modulate mRNA export, yet it is not required for export
of all spliced transcripts (Gatfield and Izaurralde, 2002). Intrigu-
ingly, despite the fact that the EJC associates with many splicing
cofactors such as RNPS1 and SRM160 and also interacts with
the core spliceosome (Bessonov et al., 2008; Herold et al.,
2009; Merz et al., 2007), it has not been implicated in pre-
mRNA splicing per se and is therefore considered to be exclu-
sively dedicated to postsplicing events.
Here, we investigated the function of the EJC in RAS/MAPK
signaling. We show that the EJC acts downstream of MEK in
the RAS/MAPK cascade and is required for MAPK expression.
Unexpectedly, we found that the EJC controls the splicing of
mapk pre-mRNAs as its disruption leads to exon skipping
events. Interestingly, RNA-Seq and RT-PCR data revealed that
the alteredmRNA expression profile provoked by EJC disruption
was not a general phenomenon, but instead correlated with
intron length, whereby pre-mRNAs bearing very large introns,
such as those of mapk, were more sensitive to EJC depletion.
Given that exon exclusion was observed for several transcripts
in addition to mapk, we propose that the EJC is involved in
exon definition of large intron-containing genes. Together, our
findings reveal a critical factor that controls RAS/MAPK signaling
in Drosophila and unveils a role for the EJC in the splicing regu-
lation of long intron-containing genes.
RESULTS
EJC Components Modulate RAS1 Signaling
Downstream of MEK
Expression of a constitutively activated form of Drosophila RAS1
(RAS1V12) in S2 cells leads to sustained activation of endoge-
nous MAPK that is quantitatively measurable by immunohisto-
chemistry (Figure 1A and see Experimental Procedures). We252 Cell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc.
used this assay to conduct a genome-wide RNAi screen to iden-
tify novel fly genes that modulate signaling through the RAS1/
MAPK pathway. Approximately 100 validated hits were identi-
fied, of which two-thirds of the known components of the
pathway were found including raf/phl, mek/Dsor1 and mapk/rl
(D.A.-B., unpublished data). Interestingly, among the candidate
genes, the three components of the nuclear EJC (eIF4AIII,
mago and tsu) were identified as suppressors considering that
the average phospho-(p)MAPK signal per cell was found to
decrease consistently upon knockdown of their respective tran-
scripts (Figure 1B and Figures S1A and S1B available online).
This indicates that the EJC positively contributes to pathway
activity at a step between RAS1 and MAPK. Intriguingly,
although the peripheral EJC component RnpS1 was also found
as a suppressor (Figures S1A and S1C), btz, the fourth core
component that is part of the cytoplasmic EJC, was not identi-
fied in the RNAi screen. Subsequent experiments confirmed
that knockdown of btz did not reduce pMAPK levels (Fig-
ure S1A), even though the dsRNA targeting btz did efficiently
deplete its transcript levels (Figure S1B) as did the dsRNAs tar-
geting mago, tsu, eIF4AIII and RnpS1 (Figures S1B and S1C).
In addition to suppressing RAS1V12, depletion of the nuclear
EJC also reduced pMAPK induced by upstream RTKs including
EGFR, SEVS11 and the insulin receptor (InR), but did not
suppress RAC1V12-induced JNK signaling (Figures 1A and 1C).
This indicates that the EJC is required for RTK/RAS1/MAPK
signaling, but is not required in the context of the RAC1/JNK
pathway. Next, we assayed the position of the EJC’s effect
with regards to the kinase cascade downstream of RAS1. Epis-
tasis experiments conducted using several cell lines expressing
constitutively active forms of RAF and MEK also showed
a consistent decrease in pMAPK levels upon EJC knockdown
(Figures 1A and 1B and Figure S1D). In contrast, cnk, a regulator
of RAF activation (Douziech et al., 2003), suppressed RAS1V12,
but not active RAF or MEK (Figure 1B). Thus, these results place
the requirement for EJC activity at a step downstream of MEK.
To determine whether the ability of the EJC tomodulate RAS1/
MAPK signaling was not restricted to S2 cells, but also controls
this pathway in vivo, we conducted genetic interaction experi-
ments using eIF4AIII, mago and tsu loss-of-function alleles.
RTK-induced RAS1/MAPK activity is required for neuronal
photoreceptor and cone cell differentiation during Drosophila
eye development (Wassarman et al., 1995). Expression of
Ras1V12 under the control of the eye specific sev promoter/
enhancer regulatory sequences produces extra photoreceptor
cells, which causes a characteristic rough eye phenotype (Fortini
et al., 1992) that has been extensively used in genetic interaction
assays (Karim et al., 1996; Therrien et al., 2000). As shown in
Figure 2A, this rough eye phenotypewas dominantly suppressed
by heterozygous mutations in the eIF4AIII, mago or tsu genes.
Four additional genetic interaction assays also tied EJC activity
to RAS1/MAPK signaling in vivo. First, the lethality associated
with raf/phl12 hemizygous mutant males was enhanced in
eIF4AIII, mago or tsu heterozygous backgrounds (Figure S2A).
Second, wing vein deletions and lethality caused by a hemizy-
gous mutation in csw, which encodes a Shp-2 phosphatase
homolog (Perkins et al., 1992), were enhanced by a mago1
heterozygous allele (Figures 2B and Figures S2B and S2C).Third, extra wing vein material produced by a constitutively
active Egfr allele was dominantly suppressed by eIF4AIII, mago
or tsu mutant alleles (Figures 2C and Figures S2D–S2F). Finally,
the rough eye andwing vein deletion phenotypes of homozygous
mapk/rl1, which corresponds to a hypomorphic allele of the
mapk/rl gene, strongly increased in severity in heterozygous
mago mutant backgrounds (Figures 2D and 2E). Collectively,
these data provide compelling evidence that the EJC is required
for RAS1/MAPK signaling in Drosophila.
The EJC Regulates Drosophila MAPK Protein
Expression
In light of the EJC function in mRNA translation (Tange et al.,
2004), we investigated the effects of its depletion on the protein
levels of selected RAS1/MAPK pathway components. Strikingly,
western blot analysis revealed that MAPK levels were signifi-
cantly reduced upon the knockdown of EJC components
(Figure 3). This effect appeared to be specific toMAPK as disrup-
tion of the EJC did not have an appreciable effect on the protein
levels of other pathway components, such as RAS1, RAF, MEK,
or CNK, on other kinases such as AKT and JNK, or on Actin
(Figure 3). Moreover, silver-stained protein lysates from EJC-
depleted S2 cells did not show any significant difference
compared to control cells, thus providing additional evidence
that EJC depletion does not lead to a global reduction of protein
levels in S2 cells (Figure S3A and see below). Interestingly, we
noticed that the levels of ectopically-produced MAPK from
amapk cDNA were insensitive to EJC depletion, which indicates
that the effect of the EJC on MAPK does not occur following its
translation (Figure S3B). Together, these findings provide an
explanation as to why EJC depletion consistently reduced
endogenous pMAPK levels in the various RAS1/MAPK signaling
assays presented above and suggest that the EJC is specifically
involved in MAPK protein expression at a step that precedes its
translation or that occurs concomitantly.
To verify whether the EJC controls MAPK levels in vivo as it
does in S2 cells, we generated mago homozygous mutant
clones during eye development and stained third instar eye-
antennal discs using an anti-MAPK antibody. In agreement
with the cell culture data, both MAPK and pMAPK levels were
strongly reduced in mago mutant clones, whereas CNK was
unaffected (Figures 4A and 4D and Figure S4A). Similar results
were obtained when mago, tsu or mapk itself were clonally
depleted by RNAi (Figures 4B and 4C and Figure S4B). Consis-
tent with reduced MAPK levels, EJC depletion during eye devel-
opment significantly impeded photoreceptor and cone cell
differentiation (Figures 4E and 4F). Together, these results indi-
cate that the EJC plays a critical role in establishing proper
MAPK protein levels in vivo.
Loss of EJC Activity Induces Exon Skipping Events
during Mapk Pre-mRNA Splicing
Given the role that the EJC plays in several aspects of mRNA
maturation, we investigated the effect of EJC disruption on
mapk transcript levels. An initial RT-qPCR evaluation of mapk
transcript levels showed a reproducible 1.5- to 2-fold decrease
upon EIF4AIII and MAGO depletion, whereas, consistent with
the results from the functional assays, mapk transcript levelsCell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc. 253
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Figure 2. Components of the EJC Geneti-
cally Interact with RAS1/MAPK Pathway
Components
(A) Ras1V12 rough eye phenotype is dominantly
suppressed by heterozygous mutations in EJC
components. Fly eyes of the indicated genotypes
were scored for severity of the rough eye pheno-
type (n > 30) and classified as strong, medium
or weak. All of the EJC alleles scored as medium
to strong suppressors. Representative ESEM
microscopy images are presented here. The
mapk/rlS-352 allele is used as a positive control.
Anterior is to the right.
(B) Enhancement of cswlfwing vein phenotypes by
mago1 loss-of-function allele. A wild-type wing is
shown as a reference (left panel). The character-
istic deletion of the distal end of the L5 (and some-
times L4 and L2) wing veins typically observed in
cswlf hemizygous males is shown (central panel)
as well as the enhanced phenotype observed in
mago1 heterozygous background (right panel).
Quantification of the enhancement is presented
in Figure S2C.
(C) Suppression of Egfr gain of function wing vein
phenotype. Typical extra wing vein material
produced by the EgfrElp gain of function allele
near the distal end of the L2 vein is shown in the
left panel (arrow). Suppression of the phenotype
by the heterozygous mapk/rl1 allele (positive
control; central panel) or by heterozygous mago1
(right panel) is also shown and quantification of
the effect is presented in Figure S2E.
(D and E) Enhancement of mapk/rl1 homozygous
rough eye and wing vein phenotypes by two
distinct mago alleles. Vein deletions (L4 mainly,
arrow) and smaller/rougher eyes are observed in
heterozygous mutant backgrounds for mago1
and mago3.did not decrease upon knockdown of btz (Figure 5A). While the
reduction in the amount of mapk mRNA was reproducible, it
did not appear sufficient to account for the decrease in protein
expression. Therefore, we examinedwhethermapkmRNA trans-
lation might be affected upon EJC depletion by comparing its
incorporation into polysomes between control and MAGO-
depleted cells. While the expected 1.5- to 2-fold decrease
in mapk mRNA levels in MAGO-depleted cells was observed,
no difference in polysome incorporation efficiency could be
detected (Figures S5A–S5C). This suggests that the EJC does
not directly impact mapk translation, nor significantly influence
processes that would lead to a decrease in translation efficiency.
Also, the fact that btz was not involved in this function further254 Cell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc.implied that the effect occurred at an
earlier step in mapk expression involving
the nuclear EJC heterotrimer.
In order to confirm the RT-qPCR
results, we surveyed mapk mRNA by
northern blot and RT-PCR analyses. In
both cases, a reduction in the amount
of the expected mapk transcripts was
apparent upon EJC depletion, butsurprisingly, truncated mapk transcripts were also visible in
these samples (Figures 5B and 5C). Specifically, transcript size
distribution, as assayed by northern blot, showed that the two
previously described mapk transcripts of 1.7 and 2.7 kb
(Berghella and Dimitri, 1996) were detected in control S2 cells
(Figure 5B, lane 1). Both transcripts were significantly reduced
upon EJC depletion and at least two novel transcripts of 1.1
and 2.1 kb could be detected (Figure 5B, lanes 3–4). Notably,
the reduction in total mapk mRNA levels observed in EJC-
depleted samples was comparable to those observed by RT-
qPCR. Also, RT-PCR with primers in the 50 and 30 UTRs of
mapk mRNA, which were expected to amplify the predicted
RB, RD, RE and RF isoforms, revealed a significant decrease
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Figure 4. Depletion of EJC Components Reduces MAPK Levels
In Vivo and Impacts Photoreceptor Cell Differentiation
(A–C) MAPK staining of third instar larval eye discs. (A) MAPK levels are under
detection levels inmago3 mutant clones, which are marked by the absence of
GFP fluorescence. MAPK is also absent in GFP-positive clones expressing
mago (B) and tsu (C) RNAi.
(D–F) mago dsRNA-expressing clones marked by GFP fluorescence impede
typical RTK-dependent signaling markers in third instar larval eye discs. (D)
Phospho-MAPK (pMAPK) signal that is normally induced by EGFR signaling
in cell clusters along the morphogenetic furrow (arrow) and in a limited set of
cells posterior to it, is abrogated in mago dsRNA-expressing cells. (E and F)
mago dsRNA-expressing cells are impaired in their ability to differentiate as
neurons or cone cells as expression of the neuronal marker ELAV (E) or the
cone marker CUT (F) is eliminated or significantly reduced in those cells. In
all panels, anterior is to the right.in the amount of the expected transcripts following EJC deple-
tion (Figure 5C, compare lane 1 to lanes 3–6). Similar to the
northern blot, several truncated species could be observed in
EJC-depleted samples by RT-PCR. In agreement with our
previous observations, this effect on the mapk transcripts was
observed for eIF4AIII, mago, tsu and RnpS1 RNAi (Figure 5C,
lanes 3–6), but not in btz dsRNA-treated cells (Figure 5C, lane 7).
Finally, in support for the specificity of this effect, jnk/bsk full-
length transcripts did not show any discernable change in abun-
dance nor size when amplified by RT-PCR from EJC-depleted
samples compared to control (Figure 5C, compare lane 8 to
lanes 10–13).
In order to ascertain the nature of these truncated transcripts,
we cloned and sequenced several RT-PCR products from both
control cells and cells depleted of eIF4AIII. Remarkably, this
analysis revealed that the shorter transcripts could be accounted
for by a series of exon skipping events (Figure 5D). The vast
majority of these events involved the precise skipping of multiple
consecutive exons with the first exon being joined to different
downstream exons at their expected 30 splice acceptor site. In
agreement with the RT-PCR data, the most commonly observed
transcripts in the eIF4AIII-depleted samples were those lacking
exons II to III, II to IV, and II to V (Figures 5C and 5D). A compila-
tion of all skipping events revealed that exon II was the most
frequently skipped exon (96% of the cases), followed by exon
III (89%) (Figure S5E). As exons II and III include the start codon
and a substantial portion of the kinase domain of MAPK, their
absence in most mapk transcripts from EJC-depleted cells
explains why EJC depletion leads to severe reduction in MAPK
protein levels. Surprisingly, exon skipping was also observed,
but to a limited extent, in control S2 cells (Figures 5C and 5D)
and could also be observed in RNA samples prepared from flies
at all developmental stages (Figure S5D). This indicates that
exon skipping during the splicing of themapk pre-mRNA occursCell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc. 255
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Total RNA was prepared from S2 cells treated with the indicated dsRNA. (A) mapk/rl transcript levels were assayed by RT-qPCR as described in the methods.
Results are the average of three independent experiments (±SD). Statistical significance was evaluated using a two-tailed Student’s t test (asterisk denotes
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suggest that the nuclear EJC plays a critical role in exon inclusion
during mapk pre-mRNA splicing.
Intron Length Determines the EJC’s Effect on Splicing
Given that the EJC is thought to generally bind to intron-contain-
ing mRNAs (Le Hir et al., 2000), we deemed unlikely that the
splicing defect we observed was unique to the mapk mRNA.
However, the observation that EJC depletion had no effect on
the expression of several other proteins encoded by intron-con-256 Cell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc.taining genes indicated that splicing in general does not require
the EJC. Thus, in order to evaluate the full spectrum of the EJC’s
effects on the transcriptome of S2 cells, we conducted a tran-
scriptional profiling experiment using massively parallel RNA
sequencing (RNA-Seq) technology on a SOLiD platform (Applied
Biosystems) that yielded highly reproducible transcript coverage
across samples (Figure S6A). The abundance of 6760 expressed
transcripts (53 coverage threshold) assayed in this manner
revealed that mapk was among the 50 genes whose expression
was most reduced upon EJC depletion (Figure 6, Figure S6B,
Figure 6. The Impact of the EJC on Transcript Levels Correlates with Intron Length
Poly(A)+, rRNA-depleted mRNAs from eIF4AIII, mago and GFP dsRNA-treated S2 cells were subjected to RNA-Seq on the SOLiD sequencing platform.
(A) eIF4AIII knockdown causes a systematic and gradual downregulation of transcripts log2(fold-change) in a manner proportional to the length of the longest
intron of the gene. mapk is among the 50 most downregulated gene detected by transcriptome analysis. The lt, tequila, PMCA, sxc and Dbp80 transcripts
that were subjected to further validation are labeled in red and eIF4AIII, in green. The Venn diagram depicts the overlap between the groups of 2-fold downregu-
lated transcripts and genes containing long introns (>1000 bp).
(B)mago and eIF4AIII depletion yield a reproducible decrease of themapkmRNA abundance together with other long intron-containing transcripts. Transcripts
that were further validated are labeled in red. eIF4AIII and mago mRNAs are depicted in green and served as internal controls.and Table S1). Therefore, the mapk transcript is highly sensitive
to perturbation of the EJC in comparison with most other genes
expressed in S2 cells.
We next sought to determine what characteristics of mapk
determined this sensitivity to the EJC.We noted three character-
istics that distinguish mapk from other fly genes. First, mapk is
localized in the pericentromeric constitutive heterochromatin.
Second, the first exon which we found to be aberrantly joined
to other downstream exons has a noncanonical splice donor
site (the first three intronic residues, GUU, do not match the
GUR consensus; Mount et al., 1992). Finally, mapk has introns
of larger than average size, including one 25 kb intron, which
is among the longest introns in the genome; less than 1% of
D. melanogaster introns are larger than 25 kb (Figure S6C). Of
these three characteristics, intron length emerged as the deter-
mining factor of the EJC’s effect. While localization in hetero-
chromatin or the presence of atypical splice sites did somewhat
correlate with sensitivity to EJC depletion, this effect was depen-
dent on the presence of long introns. Indeed, genes with these
characteristics, but with introns shorter than 250 bp were not
found to be sensitive to the EJC’s effect (Table S2). On the other
hand, transcripts with long introns were more likely to be
sensitive to EJC depletion (Table S2, Figures 6A and 6B, and
Figure S6B). Additionally, this sensitivity appeared to increase
as a function of intron length in such a manner that a general
trend could be observed for the entire population of transcripts
after both eIF4AIII and mago knockdowns (Figures 6A and 6B,
and Figure S6B). This relationship between EJC sensitivity and
intron length is highly significant since 81 out of the 114 genes
downregulated by more than 2-fold after eIF4AIII depletion had
an intron larger than 1000 bp (p value = 8.593 1021 (calculated
with a hypergeometric distribution) (Figure 6A)).Following this observation, we sought to verify whether the
fold-changes in transcript levels detected by RNA-Seq were
due to splicing defects similar to those observed for the mapk
transcript. Therefore, we performed RT-PCR on a subset of
candidate transcripts which were affected by EJC depletion
and also contained long introns. We found that a similar reduc-
tion in the levels of the full-length transcript could be observed
and, in many cases, truncated products were also detected in
EJC-depleted cells (Figure 7A), suggesting that splicing was
also altered in these cases. Indeed, sequencing of the products
for the PMCA, lt, and Tequila genes showed that exon skipping
was, in large part, responsible for the appearance of the trun-
cated products (Figure S7). In contrast, a set of control tran-
scripts with multiple exons and whose introns were all smaller
than 250 bp did not show additional truncated isoforms or
variation in abundance upon EJC depletion (Figure 7B). These
results demonstrate a clear link between intron length, splicing
and the EJC.
Finally, to complement our comprehensive study of transcript
abundance after EJC depletion, we wanted to determine
whether protein levels were accordingly modulated upon EJC
knockdown in an intron length-dependent manner. For this, we
used a nonbiased, label-free quantitative proteomics approach
to globally assess the abundance of proteins in S2 cells depleted
for the EJC (see Extended Experimental Procedures and
Figure S6D). Of the 6760 expressed transcripts detected by
RNA-Seq, we were able to correlate the abundance of 2410
corresponding proteins. Interestingly, no dramatic change was
observed in the EJC-depleted proteome and no global trend
could be found between protein fold-change and intron length
(Figures S6E and S6F). This observation is consistent with
western blot analysis of several proteins (Figure 3) and with theCell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc. 257
GFPeIF4
AIII
ma
go
Rnp
S1
btz
Dbp80
(RB)
lt
(RA / RB / RC)
PMCA
(RJ / RM)
sxc
(RA / RB / RC)
Teq
(RA / RE)
CG9149
(RA)
CG10417
(RA / RB)
CG8042
(RA)
Dbp45A
(RA)
sip3
(RA)
GFPeIF4
AIII
ma
go
Rnp
S1
btz
RNAi
RNAi
A
B
GFPeIF4
AIII
ma
go
Rnp
S1
btz GFPeIF4
AIII
ma
go
Rnp
S1
btz GFPeIF4
AIII
ma
go
Rnp
S1
btz GFPeIF4
AIII
ma
go
Rnp
S1
btz
GFPeIF4
AIII
ma
go
Rnp
S1
btz GFPeIF4
AIII
ma
go
Rnp
S1
btz GFPeIF4
AIII
ma
go
Rnp
S1
btz GFPeIF4
AIII
ma
go
Rnp
S1
btz
Figure 7. Truncated Transcripts Are Observed for Other EJC targets
Total RNA was prepared from S2 cells treated with the indicated dsRNA. RT-PCR products for EJC-sensitive transcripts (A) and EJC-insensitive transcripts (B)
were resolved on agarose/EtBr gels. Specific transcript isoforms targeted by RT-PCR are indicated in parentheses. Each of the transcripts assayed in (A) has at
least one large intron (>1000 bp), while the transcripts in (B) have at least five exons, but no introns longer than 200 bp.general aspect of silver-stained protein lysates from EJC-
depleted S2 cells (Figure S3A). Nonetheless, MAPK, PMCA
and SXC were among the most significantly downregulated
protein products in both eIF4AIII and mago-depleted samples
compared to GFP dsRNA-treated cells (Figures S6E–S6G).
This absence of strong correlation between transcript and
protein abundance has been known for some time (Gygi et al.,
1999) and is attributed to the contrasting stability of mRNAs
and proteins, especially in the context of short-term depletion
of the EJC by RNAi. This global analysis of transcript and protein
levels shows that most of the effect of EJC depletion is mani-
fested at the level of transcript abundance and splicing and
that mapk is one of the most sensitive targets of the EJC.
DISCUSSION
Previous work has chiefly associated the EJC to the control of
postsplicing events. Here, we describe a function for the nuclear
EJC in the regulation of splicing. This function is not universal,
because in the context of RAS1/MAPK signaling it was limited
to mapk. Our observation that intron length determines sensi-
tivity to EJC depletion provides an explanation for this. Impor-258 Cell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc.tantly, this also provides an important insight into the splicing
of transcripts with long introns, which suggests that the EJC is
required for exon definition in this context.
Splicing of short introns (<200 bp) occurs via the recognition of
50 and 30 splice sites across the intron (intron definition). The
process differs in long introns (>250 bp), where bordering exons
require a priori recognition of their respective splice sites across
the exon before splicing can occur (exon definition) (Fox-Walsh
et al., 2005; Sterner et al., 1996). Exon definition is less robust
than intron definition, and is thus thought to be more permissive
to regulation (Fox-Walsh et al., 2005; Sterner et al., 1996).
Consistent with this, long genes with multiple exons tend to
present more alternative splice variants (Budagyan and Loraine,
2004) and exons bordered by large introns are much more
likely to be excluded (Fox-Walsh et al., 2005; Kim et al., 2007;
McGuire et al., 2008; Roy et al., 2008). This correlation is more
pronounced in lower eukaryotes, where large introns are
comparatively rare and seem to act as major determinants of
alternative splicing (Fox-Walsh et al., 2005). In vertebrates, the
presence of additional modes of regulation is thought to explain
the less predominant impact of intron size. Still, it remains
unclear whether the effect of long introns on alternative splicing
involves specific protein factors, although the binding of multiple
hnRNPs to long introns has been proposed as one explanation
for this effect (Fox-Walsh et al., 2005).
Our finding that the EJC is associated with exon definition in
transcripts containing long introns suggests that the nuclear
EJC is one of the factors determining alternative splicing in this
context. Importantly, among the different types of alternative
splicing events, exon exclusion – often of multiple consecutive
exons – was the salient feature of EJC disruption. This is consis-
tent with previous reports that exon exclusion is predominantly
associated to long introns (Fox-Walsh et al., 2005; Kim et al.,
2007; McGuire et al., 2008). However, we also observed some
intron retention and alternative donor and acceptor site usage
in the transcripts we sequenced (Figure 5 and Figure S7). In addi-
tion to these splicing changes, EJC disruption also caused
a reduction in transcript levels of genes with long introns (Figures
6 and 7). This may be due to a lower stability of the new transcript
variants or to other splicing defects culminating in the degrada-
tion of the RNA product.
As introns tend to be larger in higher eukaryotes compared to
Drosophila and other lower eukaryotes (Fox-Walsh et al., 2005;
Kim et al., 2007; McGuire et al., 2008), it will be interesting to
verify the extent to which the EJC is involved in splicing in higher
eukaryotes. With respect to the MAPK genes, it is intriguing
to note that human MAPK1/ERK2 bears an intron just under
60 kb, which is significantly above the average human intron
length (Lander et al., 2001). In contrast,MAPK3/ERK1 has signif-
icantly smaller introns, raising the possibility that these two
MAPK genes bear different sensitivities to regulation by the EJC.
Despite the fact that the core components of the nuclear EJC
have not been previously linked to splicing, they have been
shown to associate with the spliceosome during splicing and
before actual deposition of the EJC on the mRNA (Gehring
et al., 2009; Merz et al., 2007). Furthermore, deposition of
EIF4AIII upstream of the exon junction site has been found to
occur during the second step of the splicing reaction, before
cleavage of the 30 splice site (Gehring et al., 2009). Thus, these
previous observations do not preclude an involvement of the
nuclear EJC in the splicing process.
The cytoplasmic EJC, which includes BTZ, is required for
oskar mRNA localization and translation in Drosophila (Hachet
and Ephrussi, 2004; Mohr et al., 2001; van Eeden et al., 2001).
However, btz depletion did not influence MAPK activity, nor
did it cause reduction in mapk mRNA or protein levels. Though
BTZ is sometimes described as a core EJC component, EJC
complexes devoid of BTZ have been found to associate with
the spliceosome (Bessonov et al., 2008; Herold et al., 2009;
Merz et al., 2007), and human EIF4A3, RBM8A/Y14 andMAGOH
have been shown to form a trimeric complex in the absence of
MLN51/BTZ (Ballut et al., 2005; Gehring et al., 2009). Further-
more, BTZ deposition on the mRNA has been found to occur
after completion of the splicing reaction (Gehring et al., 2009).
Also, whereas MAGO, TSU and EIF4AIII have been described
as being mainly located in the nucleus and in nuclear speckles
(Le Hir et al., 2001a; Palacios et al., 2004), BTZ bears a nuclear
export signal and is predominantly cytoplasmic at steady state
(Degot, 2004; Macchi et al., 2003; Palacios et al., 2004). Thus,
BTZ is likely not involved in nuclear events regulated by theEJC, which is consistent with our observation that btz depletion
does not impact the splicing of mapk or of other pre-mRNAs
(Figure 5C and Figure 7A).
While the EJC has not been previously implicated in splicing,
this is not the case for some EJC-associated factors such as
the SR (serine/arginine-rich) factors RNPS1 and SRM160. SR
factors are important determinants of constitutive and alternative
splicing (Long and Caceres, 2009). RNPS1 was initially charac-
terized as a splicing factor (Mayeda et al., 1999), and has since
been shown to regulate alternative splicing through alternate
exon usage (Sakashita et al., 2004) and to enhance spliceosomal
activity (Trembley et al., 2005). The fact that we also identified
RNPS1 as a factor linked to the EJC’s splicing function is consis-
tent with this and further suggests that the recruitment of RNPS1
or other SR factors could provide an additional level of specificity
to the EJC’s effect. In support of this idea, our RT-PCR data
showed that RnpS1 did not impact the splicing of all EJC target
genes (Figure 7). Importantly, RNPS1 takes part in more than
one aspect of the EJC’s functions as it is also linked to NMD
(Lykke-Andersen et al., 2001) and translational enhancement
(Nott et al., 2004; Wiegand et al., 2003). SRM160, another
EJC-associated SR factor, has also been shown to function as
a splicing coactivator which binds to exonic splicing enhancers
via other SR factors (Blencowe et al., 1998; Eldridge et al., 1999).
However, SRm160 knockdown had modest effects on MAPK
expression and no splicing defects in mapk could be observed
by RT-PCR (data not shown). Interestingly, SRM160 and
RNPS1 also promote pre-mRNA 30 end cleavage, but only
SRM160 can function independently of the EJC in this context
(McCracken et al., 2002; McCracken et al., 2003), indicating
that its activity can be uncoupled from that of the EJC. Still,
it is possible that this component acts in concert with the EJC
in the splicing of other transcripts.
One important issue raised by our findings is whether the
EJC’s effect on splicing is regulated, or if it is part of a constitutive
process involved in exon definition. EJC activity is known to be
regulated in the context of translational enhancement where
mTOR signaling modulates this activity via the EJC cofactor,
SKAR (Ma et al., 2008). A similar mechanism involving EJC
cofactors could also be responsible for bridging different inputs
with the regulation of splicing. Accordingly, the CK2 kinase has
been found to phosphorylate RNPS1 and regulate its splicing
activity (Trembley et al., 2005). More generally, the control of
alternative splicing through SR and hnRNP factors is regulated
by different signaling events (House and Lynch, 2008; Stamm,
2008). For example, the RAS/MAPK dependent regulation of
CD44 splicing occurs via the SRM160 and SAM68 SR factors
(Cheng and Sharp, 2006). Thus, SR factors could provide
further specificity and signal-integration properties to the
EJC’s function in splicing. Further investigation of the splicing
changes brought about by cofactors such as RNPS1 will help
to understand their contribution to EJC-regulated splicing.
Indeed, one possibility is that the EJC acts as an adaptor
platform for SR factors which are required for exon definition.
In this model, the individual SR factors would be the effectors
involved in providing specificity to splice site selection. Alterna-
tively, it is possible that the EJC also directly impacts splice
site selection (and exon definition) by masking either bindingCell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc. 259
sites for other splicing factors or RNA motifs directly involved in
splice site selection (Yu et al., 2008). A third possibility is that the
EJC stabilizes the interaction of spliceosome complexes with
splice sites and that this is of particular importance for exon
definition. Investigation of these possibilities will be important
in order to further understand the EJC’s role in splicing at the
mechanistic level.
The example of CD44 is of particular interest in the context of
this study as themodulation of CD44 also constitutes a feedback
mechanism that regulates RAS activity (Cheng and Sharp, 2006;
Cheng et al., 2006). Since we initially identified the EJC as specif-
ically regulating mapk expression in the context of the RAS1/
MAPK pathway, and asmapkwas among themost highly modu-
lated EJC targets, both at the mRNA and protein level, the
control of mapk splicing, like CD44, may also be a key element
in modulating signal flow. The identification of the inputs regu-
lating the splicing of mapk via the EJC will provide additional
insights into how signal modulation is achieved through this
route. Also, although many signaling genes are known to encode
alternatively spliced transcripts with different functions, the
extent to which regulation of signaling processes is achieved
by splicing is still largely underappreciated.
EXPERIMENTAL PROCEDURES
Quantitative Immunofluorescence Microscopy
S2 cell lines were distributed in 96-well clear plates (Corning) containing a final
concentration of 200 ng/mL dsRNA. Cells were then fixed, blocked and incu-
bated overnight with a primary antibody (anti-pMAPK 1/2000, Sigma #M8159
or an anti-pJNK 1/500, NEB #9251S), then stained with a secondary antibody
(anti-mouse Alexa Fluor 555-conjugated 1/1000, Invitrogen #A-21424) and
with DAPI. Cells were mounted in Mowiol (9.6% PVA, Fluka). An automated
fluorescence microscopy system (Zeiss Axiovert) was employed for plate
imaging. Autofocus, image acquisition and analysis were conducted using
MetaMorph (MolecularDevices) software. Thecell-scoringapplication inMeta-
Morph was used for quantitative image analysis. Information on cell lines and
cell culture conditions is included in the Extended Experimental Procedures.
Fly Genetics, Immunohistochemistry, and ESEM
Fly husbandry was conducted according to standard procedures. Crosses to
raf/phl12 flies were performed at 18C. All other crosses were performed at
25C. The sev-RasV12 and raf/phl12 (formerly referred to as rafHM7) lines have
been described previously (Karim et al., 1996; Melnick et al., 1993). EgfrElp
was described in (Baker and Rubin, 1989). The cswlf (Perkins et al., 1996)
was kindly provided by L. Perkins. Themago alleles were described in (Boswell
et al., 1991). RNAi fly lines were obtained from the VDRC (Dietzl et al., 2007).
All other mutant lines described herein were obtained from the Bloomington
stock center.
Homozygous mago mutant clones were generated using the flp-FRT tech-
nique (Xu and Rubin, 1993). Third instar eye discs were fixed and stained
with anti-MAPK (1/1000, Cell Signaling #4695), anti-CUT (1/200, DSHB) and
anti-ELAV (1/20, DSHB) antibodies. Eye disc images were acquired on a Zeiss
LSM 510 laser scanning confocal microscope. Fly eyes were imaged using an
environmental scanning electron microscope (Quanta 200 FEG) or stereomi-
croscope (Leica MZ FL III). Permount-mounted wings were imaged using
a Nanozoomer (Hamamatsu).
RT-qPCR, RT-PCR, and Northern Blot
S2 cells were cultured in dsRNA (15 mg/ml) for seven days and total RNA was
prepared using TRIzol reagent (Invitrogen).
For RT-qPCR, 2 mg of total RNA was reverse transcribed using the High
Capacity cDNA Archive Kit with random primers (Applied Biosystems). PCR
reactions for 384-well plate formats were performed using 2 ml of cDNA, 5 ml260 Cell 143, 251–262, October 15, 2010 ª2010 Elsevier Inc.of the TaqMan fast Universal PCR Master Mix (Applied Biosystems), 2 mM of
each primer, and 1 mM of the Universal TaqMan probe in a total volume of
10 ml. The ABI PRISM 7900HT Sequence Detection System (Applied Biosys-
tems) was used to detect the amplification level.
For RT-PCR, 1 mg of total RNA was primed with oligo(dT)18 followed by
reverse transcription (RT) with SuperScript II Reverse Transcriptase (Invitro-
gen). 1/20 of the RT reaction was used as template for PCR.
For northern blot analyses, poly(A)+ mRNA was isolated from total S2 cell
RNA using oligotex resin (QIAGEN). mRNA samples (1.5 mg) were separated
on a 5% formaldehyde-1% agarose gel and transferred to a nylon membrane
(Hybond-N+; GE Healthcare). Hybridizations were conducted in 0.125M
Na2HPO4 (pH 7.4), 4 mM EDTA, 7% SDS.
32P-labeled probes were synthe-
sized by random priming using mapk/rl or jnk/bsk cDNA fragments.
Membranes were washed three times in 13 SSC/0.1% SDS and once in
0.13 SSC/0.1% SDS for 20 min at 65C, and then exposed for 3 days at
80C using an intensifying screen.
For additional information regarding primer sequences see the Extended
Experimental Procedures and Table S3.
Whole Transcriptome Sequencing and Analysis
Total RNA from S2 cells subjected to treatment with eIF4AIII, mago and GFP
dsRNA in duplicate and was prepared using TRIzol reagent (Invitrogen) and
Poly(A)+ mRNAs were enriched using oligo(dT) selection with the Oligotex
mRNA Midi kit (QIAGEN). The resulting mRNA was then depleted of rRNA
molecules using the Ribominus Eukaryote kit (Invitrogen). High-throughput
sequencing libraries were prepared according to the SOLiD whole transcrip-
tome library preparation protocol (Applied Biosystems). Whole transcriptome
reads were aligned using the Bioscope software package (Applied Biosys-
tems) using the UCSC Drosophila genome release 4.2 as a reference (http://
genome.ucsc.edu/). 953, 837 and 524 million reads mapped uniquely to the
reference genome and yielded an average exon coverage of 154X, 134X and
77X for the GFP, eIF4AIII and mago knocked down samples respectively.
Sequencing data have been deposited in GEO under accession number
GSE24012.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at doi:
10.1016/j.cell.2010.09.014.
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